Whiting USA Trust II EV/EBIT
¿Qué es el EV/EBIT de Whiting USA Trust II?
El EV/EBIT de Whiting USA Trust II es 0.32
¿Cuál es la definición de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT de compañías en Sector Energy en OTC en comparadas con Whiting USA Trust II
¿Qué hace Whiting USA Trust II?
Whiting USA Trust II holds a term net profits interest in the oil and gas producing properties located in the Permian Basin, Rocky Mountains, Gulf Coast, and Mid-Continent regions of the United States. Its oil and gas properties include interests in approximately 364.1 net producing oil and natural gas wells located in 42 predominately mature fields with established production profiles in 8 states. The company was founded in 2011 and is based in Houston, Texas. Whiting USA Trust II is a subsidiary of Whiting Petroleum Corporation.
Empresas con ev/ebit similar a Whiting USA Trust II
- Oncternal Therapeutics tiene EV/EBIT de 0.28
- Sulliden Mining Capital tiene EV/EBIT de 0.29
- J4 Ventures tiene EV/EBIT de 0.29
- Sulliden Mining Capital tiene EV/EBIT de 0.30
- Bio-Path Inc tiene EV/EBIT de 0.31
- Freeline Therapeutics plc tiene EV/EBIT de 0.31
- Whiting USA Trust II tiene EV/EBIT de 0.32
- Valencia Capital tiene EV/EBIT de 0.33
- BlueCity tiene EV/EBIT de 0.33
- Aclaris Therapeutics Inc tiene EV/EBIT de 0.35
- Zafgen tiene EV/EBIT de 0.35
- Xenetic Biosciences Inc tiene EV/EBIT de 0.35
- Ocwen tiene EV/EBIT de 0.35